Effects of Dietary Milled Seed Mixture on Fatty Acid Status and Inflammatory Markers in Patients on Hemodialysis

Table 3

Serum phospholipids fatty acid composition at baseline and changes induced by dietary intervention.

Serum; fatty acids	Baseline	After treatment
16:0	25.32±2.39	23.87 ± 2.09**
18:0	16.44±1.74	15.05 ± 1.02**
SFA	41.76±3.22	38.93 ± 2.34***
16:1n-7	0.39±0.16	0.36±0.15
18:1n-9	13.83±1.68	14.92 ± 0.86*
MUFA	14.59±1.66	15.28 ± 0.94**
18:2n-6 LA	24.49±2.62	25.73 ± 1.85**
20:3n-6	2.57±0.79	2.96 ± 0.70**
20:4n-6	11.63±2.31	12.77 ± 2.56*
22:4n-6	0.56±0.14	0.61 ± 0.11
n-6	39.25±3.25	42.06 ± 2.72***
18:3n-3 LNA	0.08±0.03	0.12 ± 0.02*
20:5n-3 EPA	0.18±0.05	0.22 ± 0.08*
22:5n-3	0.46±0.07	0.51 ± 0.10*
22:6n-3 DHA	2.75±0.33	2.99 ± 0.39**
n-3	3.46±0.37	3.84 ± 0.42***
PUFA	42.71±3.39	45.90 ± 2.69***
n-6/n-3 ratio	11.34±1.25	10.91 ± 1.59
PUFA/SFA ratio	1.03±0.15	1.10 ± 0.14***

The values are means ± SD. ∗P ≤ 0.05, **P ≤ 0.01, and ^{* * *}P ≤ 0.001 significantly different from baseline.